Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline (2020)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; PESSOA JUNIOR, ADALBERTO - FCF ; LOPES, LUCIANA BIAGINI - ICB ; MIGUEL, RODRIGO DOS ANJOS - ICB ; APOLINÁRIO, ALEXSANDRA CONCEIÇÃO - ICB ; HIRATA, AMANDA SOARES - ICB
- Unidades: ICB; FCF
- DOI: 10.2217/nnm-2020-0290
- Subjects: FARMACOLOGIA; NEOPLASIAS MAMÁRIAS; NANOTECNOLOGIA; ANTINEOPLÁSICOS; QUIMIOTERÁPICOS; MELANOMA; FARMACOS; MEDICAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Nanomedicine
- ISSN: 1743-5989
- Volume/Número/Paginação/Ano: v. 15, n. 26, p. 2539–2542
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, v. 15, n. 26, p. 2539–2542, 2020Tradução . . Disponível em: https://doi.org/10.2217/nnm-2020-0290. Acesso em: 31 mar. 2026. -
APA
Apolinário, A. C., Hirata, A. S., Miguel, R. dos A., Costa-Lotufo, L. V., Pessoa Junior, A., Clair, J. J. L., et al. (2020). Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, 15( 26), 2539–2542. doi:10.2217/nnm-2020-0290 -
NLM
Apolinário AC, Hirata AS, Miguel R dos A, Costa-Lotufo LV, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2026 mar. 31 ] Available from: https://doi.org/10.2217/nnm-2020-0290 -
Vancouver
Apolinário AC, Hirata AS, Miguel R dos A, Costa-Lotufo LV, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2026 mar. 31 ] Available from: https://doi.org/10.2217/nnm-2020-0290 - Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs
- Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase
- Novel lipid nanovesicle-loaded dissolving microarray patches for fenretinide in breast cancer chemoprevention
- Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma
- Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment
- Lipid nanovesicles for biomedical applications: ‘what is in a name’?
- Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter?
- Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide
- Desenvolvimento e caracterização de polimerossomos para veiculação de L-asparaginase
- Multifunctional nanoemulsions promote cutaneous co-localization of chemotherapeutic agents and improve efficacy in 3D models of skin cancer
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
